Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127179581 | 12717958 | 1 | I | 20160830 | 20160906 | 20160906 | EXP | KR-PFIZER INC-2016410959 | PFIZER | LEE, S.. ATTENUATED FOLFIRINOX (5-FU/LV, IRINOTECAN AND OXALIPLATIN) AS SECOND-LINE CHEMOTHERAPY FOR THE KOREANS (ASIAN POPULATION) WITH GEMCITABINE-RESISTANT OR -REFRACTORY ADVANCED PANCREATIC CANCER.. JOURNAL OF CLINICAL ONCOLOGY.. 2016;34(N. 15_SUPPL) | 0.00 | Y | 0.00000 | 20160906 | OT | KR | KR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127179581 | 12717958 | 1 | SS | FLUOROURACIL. | FLUOROURACIL | 1 | Intravenous drip | 2000 MG/M2, CONTINUOUS INFUSION OVER 46 HOURS ON DAY 1-2 EVERY 2 WEEKS | U | 0 | 2000 | MG/M**2 | |||||||
| 127179581 | 12717958 | 2 | PS | IRINOTECAN HCL | IRINOTECAN HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | 135 MG/M2,ON DAY EVERY 2 WEEKS | U | 20571 | 135 | MG/M**2 | |||||||
| 127179581 | 12717958 | 3 | SS | LEUCOVORIN. | LEUCOVORIN | 1 | Intravenous (not otherwise specified) | 400 MG/M2, ON DAY 1 EVERY 2 WEEKS | U | 8107 | 400 | MG/M**2 | |||||||
| 127179581 | 12717958 | 4 | SS | OXALIPLATIN. | OXALIPLATIN | 1 | Intravenous (not otherwise specified) | 65 MG/M2, ON DAY 1 EVERY 2 WEEKS | U | 78813 | 65 | MG/M**2 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127179581 | 12717958 | 1 | Pancreatic carcinoma |
| 127179581 | 12717958 | 2 | Pancreatic carcinoma |
| 127179581 | 12717958 | 3 | Pancreatic carcinoma |
| 127179581 | 12717958 | 4 | Pancreatic carcinoma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127179581 | 12717958 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127179581 | 12717958 | Death |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |